The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112567078 11256707 8 F 201401 20160822 20150709 20160831 PER US-GLAXOSMITHKLINE-US2015GSK098459 GLAXOSMITHKLINE 54.06 YR F Y 0.00000 20160831 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112567078 11256707 1 PS VENTOLIN HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) 90 UG, U U 4ZP7172 20983 90 UG OROMUCOSAL SPRAY
112567078 11256707 2 SS VENTOLIN HFA ALBUTEROL SULFATE 1 UNK U UNKNOWN 20983 OROMUCOSAL SPRAY
112567078 11256707 3 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 500 UG, U U 5ZP7616 0 500 UG INHALATION POWDER
112567078 11256707 4 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 U 0 INHALATION POWDER
112567078 11256707 5 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 UNK UNK, U U UNKNOWN 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112567078 11256707 1 Chronic obstructive pulmonary disease
112567078 11256707 2 Emphysema
112567078 11256707 3 Chronic obstructive pulmonary disease
112567078 11256707 4 Emphysema
112567078 11256707 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
112567078 11256707 OT
112567078 11256707 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
112567078 11256707 Condition aggravated
112567078 11256707 Drug ineffective
112567078 11256707 Dyspnoea
112567078 11256707 Dyspnoea exertional
112567078 11256707 Hospitalisation
112567078 11256707 Influenza
112567078 11256707 Lung infection
112567078 11256707 Oxygen supplementation
112567078 11256707 Pneumonia
112567078 11256707 Respiratory failure
112567078 11256707 Therapeutic response decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112567078 11256707 1 2011 0
112567078 11256707 3 2014 0